A new area of outsourcing: Improve efficiency and streamline trail solutions with a personalized approach to clinical trial solution
Personalization is the new king of global outsourcing. Patients are crying out for more flexible, more diverse and less burdensome trial designs, while the ever larger CROs become less versatile with every merger. It’s no surprise that pharma is beginning to ask questions about how to receive the one-to-one attention we need to build innovative global trials.
During this webinar, Mallinckrodt Pharmaceuticals, Amsterdam UMC, Comac Medical, Peachtree and Julius Clinical explored the emerging future of outsourcing regional and global trials.
This exclusive discussion covered:
- Overcoming concerns around perceived risks and inefficiencies when building tailor-made trial solutions
- How to build an outsourcing strategy that will deliver greater design flexibility and closer working with industry expert KOL’s
- Where to find the right partners who can deliver personalized access to local sites, patient populations and scientific support
- Why developing a peer-to-peer approach with local experts results in patient-preferred trial designs, outcomes and deliverables
Panel speakers:
- Anne Marie Inglis, PhD, Senior Director, Clinical Operations, Mallinckrodt Pharmaceuticals
- Dr. Philip Scheltens, Professor of Cognitive Neurology and Director of the Alzheimer Center, Amsterdam UMC
- Tsvetelina Ivanova, Chief Compliance Manager, Comac Medical
- Keith Coffee, SVP Medical and Scientific Affairs, Peachtree
- Hans van Dijk, Chief Operating Officer, Julius Clinical
Related webinars
Webinar: Selecting and successfully integrating cognitive testing into clinical trials
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed: Cognitive domains – which ones sh...
Upcoming webinar: Real-World Data in ALS
We are excited to invite you to our webinar exploring the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved pa...
Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire Speakers: Dr. Sietske Sikkes | Associate Professor a...